David D. Chang - President and CEO, Director at Allogene Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
ALLO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

David D. Chang - trading volume in the past year for Allogene Therapeutics, Inc.

Holdings reported by David D. Chang for Allogene Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to buy) 1.95M $10.8M $9.62 Jan 24, 2025 Direct Common Stock
Common Stock 5.28M $10.3M $1.96 Mar 14, 2025 Direct
Common Stock 1.2M $2.35M $1.96 Mar 14, 2025 Indirect

Transactions reported by David D. Chang for Allogene Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.